Fruquintinib Combined With TAS-102 in the Treatment of Patients With Advanced Metastatic CRC
Clinical trial NCT05004831 · UNKNOWN
Trial details
- NCT number
- NCT05004831
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-11
- Primary completion
- 2023-09-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.